Treatment of patients with NAFLD, type 2 diabetes mellitus and concomitant cardiac pathology

dc.contributor.author	Pivtorak, K.	en
dc.contributor.author	Yakovleva, O.	en
dc.contributor.author	Kobirnichenko, A.	en
dc.contributor.author	Krykus, О.	en
dc.date.accessioned	2021-12-06T12:27:56Z
dc.date.available	2021-12-06T12:27:56Z
dc.date.issued	2021
dc.identifier.citation	Pivtorak K. Treatment of patients with NAFLD, type 2 diabetes mellitus and concomitant cardiac pathology / K. Pivtorak, O. Yakovleva, A. Kobirnichenko, O. Krykus // Diabetes Metabolism and the Heart : virtual CVOT Summit, 18 - 19 November 2021. - P. 15.	uk_UA
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/5509
dc.description.abstract	During the study, 38 patients with NAFLD, type 2 diabetes mellitus and concomitant CHD and AH were monitored. 56 % of those surveyed were women and 44 % were men.	uk_UA
dc.language.iso	en	uk_UA
dc.subject	nonalcoholic fatty liver disease (NAFLD)	uk_UA
dc.subject	diabetes	uk_UA
dc.title	Treatment of patients with NAFLD, type 2 diabetes mellitus and concomitant cardiac pathology	uk_UA
dc.type	Thesis	uk_UA